Reata Pharmaceuticals Statistics, Revenue Totals and Facts (2021)



Here are a few of the most interesting Reata Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Reata Pharmaceuticals Facts

  • Website: Official Website
  • Year Founded: 2002
  • Headquarters: Irving, TX
  • Founder(s): J Warren Huff

What is Reata Pharmaceuticals?

Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. (source)

Reata Pharmaceuticals Employee Count

Number of Reata Pharmaceuticals employees:

220 employees

Last updated 1/1/20


Reata Pharmaceuticals Revenue Totals

Reata Pharmaceuticals annual revenue:


Reata Pharmaceuticals annual net income:


Please note that some of these numbers are easier to find than others. A few of these Reata Pharmaceuticals stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.